September 27, 2024
Trending Now
1
FDA OKs First Niemann-Pick Type C Drug
2
Tea, Wine, Berries: Flavonoids May Lower Dementia Risk
3
Sickle Cell Stroke Rates Rise Post-STOP
4
Parkinson's Drug Achieves Main Goal in Late-Stage Trial
5
Vision Impairment Linked to Nearly One-Fifth of Dementia
6
Could Microplastics Be a Hidden Risk to Brain Health?
Conference Coverage
European Respiratory Society (ERS) Congress
September 18, 2024
Could Sulthiame Offer a New Drug Treatment for Sleep Apnea?
2024 Annual Meeting of The Menopause Society
September 17, 2024
Trauma Exposure Linked to Accelerated Brain Aging, Alzheimer's Risk
September 13, 2024
Hot Flashes at Night: Timing Matters
European Association for the Study of Diabetes Annual Meeting 2024
September 09, 2024
EASD: Insulin Resistance Tied to 31 Diseases
Clinical Guidelines
View MoreSeptember 27, 2024
New RBC Transfusion Guidelines: Restrictive Approach Prevails
September 24, 2024
Heart Guidelines Evolve for Noncardiac Surgery
August 30, 2024
ESC Tightens BP Targets in New Guidelines
May 01, 2023
Virtual Reality in Retina
Commentary & Perspectives
View MoreSeptember 26, 2024
PTSD Widespread Among Nursing Aides After ‘Nightmare’ COVID Conditions
FDA & Government News
View MoreSeptember 27, 2024
FDA Approves Cobenfy for Schizophrenia
September 26, 2024
Parkinson's Drug Achieves Main Goal in Late-Stage Trial
September 25, 2024
FDA Approves IND for Liquid Botulinum Toxin Formulation
September 20, 2024
FDA OKs First Niemann-Pick Type C Drug
Business Management
View MoreSeptember 27, 2024
U.S. Nonprofit Hospitals Gained $37.4B in 2021 Tax Benefits
September 23, 2024
Physicians Urged to Scrutinize Employers Beyond Salary
August 30, 2024